<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03879525</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00056740</org_study_id>
    <nct_id>NCT03879525</nct_id>
  </id_info>
  <brief_title>EMR Outcomes: Anxiety and Depression in Epilepsy</brief_title>
  <official_title>Anxiety and Depression in Epilepsy: Assessing Outcomes Using the Electronic Medical Record (EMR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to find out how people with epilepsy and possible symptoms of&#xD;
      anxiety or depression are doing for 6 months after a regular epilepsy clinic visit.&#xD;
      Participants in this study will complete questionnaires either by phone or via the patient&#xD;
      portal.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a study among N=30 individuals with epilepsy and high or borderline anxiety or&#xD;
      depression symptoms receiving usual care at the Wake Forest Comprehensive Epilepsy Center.&#xD;
      Participants are randomized to one of two outcome assessment methods&#xD;
      [EMR-based-interventional method vs. telephone-based-standard method] for collecting quality&#xD;
      of life, anxiety and depression outcomes at 3 and 6 months, under usual care management.&#xD;
&#xD;
      The primary aim of the study is to assess feasibility of EMR-based outcome assessment by&#xD;
      measuring 6-month retention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 16, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Actual">November 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcome group assignment will not be blinded to the primary investigator or primary study coordinator, as it will be necessary for these individuals to know outcome assessment allocation in order for outcome collection to occur. When possible, outcome group assignment will not be shared with the epilepsy provider managing the participant, in an effort to reduce any potential bias in retention that could be introduced by the provider in clinical interactions with the participant.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of participants retained in the study in the EMR arm</measure>
    <time_frame>6 months</time_frame>
    <description>Retention is defined as the percentage of participants in the study who complete the 6 month outcome instruments in the EMR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants retained in the study in the Phone arm</measure>
    <time_frame>6 months</time_frame>
    <description>Retention is defined as the percentage of participants in the study who complete the 6 month outcome instruments via phone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life in Epilepsy-10 (QOLIE-10)</measure>
    <time_frame>Baseline</time_frame>
    <description>QOLIE-10 is A brief questionnaire (10-items) to screen for quality of life in epilepsy. Total Score 10-50. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life in Epilepsy-10 (QOLIE-10)</measure>
    <time_frame>3 Months</time_frame>
    <description>QOLIE-10 is A brief questionnaire (10-items) to screen for quality of life in epilepsy. Total Score 10-50. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life in Epilepsy-10 (QOLIE-10)</measure>
    <time_frame>6 Months</time_frame>
    <description>QOLIE-10 is A brief questionnaire (10-items) to screen for quality of life in epilepsy. Total Score 10-50. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder 7-item (GAD-7) scale</measure>
    <time_frame>6 months</time_frame>
    <description>Anxiety scale. Total Score 0-28. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder 7-item (GAD-7) scale</measure>
    <time_frame>Baseline</time_frame>
    <description>Anxiety scale. Total Score 0-28. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder 7-item (GAD-7) scale</measure>
    <time_frame>3 Months</time_frame>
    <description>Anxiety scale. Total Score 0-28. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Disorders Depression Inventory (NDDI-E)</measure>
    <time_frame>Baseline</time_frame>
    <description>The NDDI-E is a 6-item questionnaire validated to screen for depression in people with epilepsy. Total Score 4-24. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Disorders Depression Inventory (NDDI-E)</measure>
    <time_frame>3 Months</time_frame>
    <description>The NDDI-E is a 6-item questionnaire validated to screen for depression in people with epilepsy. Total Score 4-24. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Disorders Depression Inventory (NDDI-E)</measure>
    <time_frame>6 Months</time_frame>
    <description>The NDDI-E is a 6-item questionnaire validated to screen for depression in people with epilepsy. Total Score 4-24. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Semi-Structured Interviews</measure>
    <time_frame>13 Months</time_frame>
    <description>Optional semi-structured interviews to assess patient-level barriers and facilitators to successfully implementing a collaborative care model of mental health care. Data will be analyzed via an inductive thematic analysis approach.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Quality of Life</condition>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>EMR Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to this arm will complete the questionnaires in the EMR using the EMR-based-interventional method.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phone Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants assigned to this arm will complete the questionnaires via the Phone using the Telephone-based-standard method.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EMR-based-interventional method</intervention_name>
    <description>Questionnaire delivery method. Participants will complete standard care anxiety and depression screening and quality of life assessment directly into the patient entered section of the EMR, administered on arrival in the clinic.</description>
    <arm_group_label>EMR Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telephone-based-standard method</intervention_name>
    <description>Questionnaires delivered via phone. Participants will complete standard care anxiety and depression screening and quality of life assessment via phone. Standart delivery method.</description>
    <arm_group_label>Phone Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
          -  Completed electronic questionnaires independently in clinic&#xD;
&#xD;
          -  Epilepsy diagnosis (clinician impression or EEG-based)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heidi M. Munger Clary, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 15, 2019</study_first_submitted>
  <study_first_submitted_qc>March 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2019</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electronic medical record</keyword>
  <keyword>EMR</keyword>
  <keyword>Patient Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Will consider requests if received.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 3, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT03879525/Prot_SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 19, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT03879525/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <pending_results>
    <submitted>November 8, 2021</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

